Clinical meaning of age-related expression of fecal cytokeratin 19 in colorectal malignancy

BMC Cancer

Volumn 9, Issue , 2009, Pages 376-

  Chang, Chun Chao ^a   Yang, Shung Haur ^b   Chien, Chih Cheng ^c,d   Chen, Shu Hung ^c   Pan, Shiann ^a   Lee, Chia Long ^c   Lin, Chih Ming ^c,d   Sun, Hsiao Lun ^c   Huang, Chi Cheng ^c,d,f   Wu, Yih Yiing ^c   Yang, Ruey Neng ^c   Huang, Chi Jung ^c,d,e  

^a TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c CATHAY GENERAL HOSPITAL   (Taiwan)

^d FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^e NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^f NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 19;

ADULT; AGED; ARTICLE; CANCER STAGING; COLORECTAL CANCER; CONTROLLED STUDY; FECES ANALYSIS; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; ONSET AGE; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR VOLUME;

EID: 70749139572     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-9-376     Document Type: Article

References (40)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer statistics, 2008. CA Cancer J Clin 2008, 58(2):71-96. 10.3322/CA.2007.0010, 18287387.
2. Srivastava S, Verma M, Henson DE. Biomarkers for early detection of colon cancer. Clin Cancer Res 2001, 7(5):1118-1126.
3. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007, 57(1):43-66. 10.3322/canjclin.57.1.43, 17237035.
4. Giatromanolaki A, Sivridis E, Koukourakis MI. Angiogenesis in colorectal cancer: prognostic and therapeutic implications. Am J Clin Oncol 2006, 29(4):408-417. 10.1097/01.coc.0000221317.56731.4e, 16891872.
5. Gradilone A, Gazzaniga P, Silvestri I, Gandini O, Trasatti L, Lauro S, Frati L, Agliano AM. Detection of CK19, CK20 and EGFR mRNAs in peripheral blood of carcinoma patients: correlation with clinical stage of disease. Oncol Rep 2003, 10(1):217-222.
6. Benoy IH, Elst H, Philips M, Wuyts H, Van Dam P, Scharpe S, Van Marck E, Vermeulen PB, Dirix LY. Real-time RT-PCR detection of disseminated tumour cells in bone marrow has superior prognostic significance in comparison with circulating tumour cells in patients with breast cancer. Br J Cancer 2006, 94(5):672-680. 2361203, 16495933.
7. Vogelstein B, Fearon ER, Hamilton SR. Genetic alterations during colorectal-tumor development. N Engl J Med 1988, 319:525-532.
8. Galan M, Vinolas N, Colomer D, Soler G, Munoz M, Longaron R, Ventura PJ, Gascon P, Estape J. Detection of occult breast cancer cells by amplification of CK19 mRNA by reverse transcriptase-polymerase chain reaction: role of surgical manipulation. Anticancer Res 2002, 22(5):2877-2884.
9. Pinzani P, Salvadori B, Simi L, Bianchi S, Distante V, Cataliotti L, Pazzagli M, Orlando C. Isolation by size of epithelial tumor cells in peripheral blood of patients with breast cancer: correlation with real-time reverse transcriptase-polymerase chain reaction results and feasibility of molecular analysis by laser microdissection. Hum Pathol 2006, 37(6):711-718. 10.1016/j.humpath.2006.01.026, 16733212.
10. Rozhkova NI, Bozhenko VK, Ploshnitsa AI, Tashchyan AA, Kudinova EA, Mazo ML. Cytokeratin 19 mRNA concentration in lymph nodes as a diagnostic marker of metastases. Bull Exp Biol Med 2008, 145(1):90-92. 10.1007/s10517-008-0039-0, 19024012.
11. Wong IH, Yeo W, Chan AT, Johnson PJ. Quantitative relationship of the circulating tumor burden assessed by reverse transcription-polymerase chain reaction for cytokeratin 19 mRNA in peripheral blood of colorectal cancer patients with Dukes' stage, serum carcinoembryonic antigen level and tumor progression. Cancer Lett 2001, 162(1):65-73. 10.1016/S0304-3835(00)00630-3, 11121864.
12. Mizuguchi S, Nishiyama N, Iwata T, Nishida T, Izumi N, Tsukioka T, Inoue K, Kameyama M, Suehiro S. Clinical value of serum cytokeratin 19 fragment and sialyl-Lewis x in non-small cell lung cancer. Ann Thorac Surg 2007, 83(1):216-221. 10.1016/j.athoracsur.2006.08.042, 17184666.
13. Wakatsuki M, Suzuki Y, Nakamoto S, Ohno T, Ishikawa H, Kiyohara H, Kiyozuka M, Shirai K, Nakayama Y, Nakano T. Clinical usefulness of CYFRA 21-1 for esophageal squamous cell carcinoma in radiation therapy. J Gastroenterol Hepatol 2007, 22(5):715-719.
14. Zhong LP, Zhu HG, Zhang CP, Chen WT, Zhang ZY. Detection of serum Cyfra 21-1 in patients with primary oral squamous cell carcinoma. Int J Oral Maxillofac Surg 2007, 36(3):230-234. 10.1016/j.ijom.2006.06.016, 16965897.
15. Leff DR, Chen A, Roberts D, Grant K, Western C, Windsor AC, Cohen CR. Colorectal cancer in the young patient. Am Surg 2007, 73(1):42-47.
16. O'Connell JB, Maggard MA, Liu JH, Etzioni DA, Livingston EH, Ko CY. Rates of colon and rectal cancers are increasing in young adults. Am Surg 2003, 69(10):866-872.
17. Karsten B, Kim J, King J, Kumar RR. Characteristics of colorectal cancer in young patients at an urban county hospital. Am Surg 2008, 74(10):973-976.
18. Koga Y, Yasunaga M, Moriya Y, Akasu T, Fujita S, Yamamoto S, Kozu T, Baba H, Matsumura Y. Detection of colorectal cancer cells from feces using quantitative real-time RT-PCR for colorectal cancer diagnosis. Cancer Sci 2008, 99(10):1977-1983.
19. Shastri YM, Naumann M, Oremek GM, Hanisch E, Rosch W, Mossner J, Caspary WF, Stein JM. Prospective multicenter evaluation of fecal tumor pyruvate kinase type M2 (M2-PK) as a screening biomarker for colorectal neoplasia. Int J Cancer 2006, 119(11):2651-2656. 10.1002/ijc.22243, 16929517.
20. Yang SH, Chien CC, Chen CW, Li SY, Huang CJ. Potential of faecal RNA in diagnosing colorectal cancer. Cancer Lett 2005, 226(1):55-63. 10.1016/j.canlet.2004.11.005, 16004932.
21. Huang CJ, Chien CC, Yang SH, Chang CC, Sun HL, Cheng YC, Liu CC, Lin SC, Lin CM. Faecal ribosomal protein L19 is a genetic prognostic factor for survival in colorectal cancer. J Cell Mol Med 2008, 12(5B):1936-1943.
22. Chien CC, Chang CC, Yang SH, Chen SH, Huang CJ. A homologue of the Drosophila headcase protein, HECA, is a novel tumor marker for early-stage colorectal cancer. Oncol Rep 2006, 15:919-926.
23. Ahlquist DA, Harrington JJ, Burgart LJ, Roche PC. Morphometric analysis of the "mucocellular layer" overlying colorectal cancer and normal mucosa: relevance to exfoliation and stool screening. Hum Pathol 2000, 31(1):51-57. 10.1016/S0046-8177(00)80198-7, 10665913.
24. Koga Y, Yasunaga M, Katayose S, Moriya Y, Akasu T, Fujita S, Yamamoto S, Baba H, Matsumura Y. Improved recovery of exfoliated colonocytes from feces using newly developed immunomagnetic beads. Gastroenterol Res Pract 2008, 2008. 605273, 2606972, 19125182.
25. Benoy IH, Elst H, Auwera I, Van Laere S, van Dam P, Van Marck E, Scharpe S, Vermeulen PB, Dirix LY. Real-time RT-PCR correlates with immunocytochemistry for the detection of disseminated epithelial cells in bone marrow aspirates of patients with breast cancer. Br J Cancer 2004, 91(10):1813-1820. 10.1038/sj.bjc.6602189, 2410046, 15505629.
26. Zhong LP, Chen WT, Zhang CP, Zhang ZY. Increased CK19 expression correlated with pathologic differentiation grade and prognosis in oral squamous cell carcinoma patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007, 104(3):377-384. 10.1016/j.tripleo.2006.07.019, 17095259.
27. Denis MG, Lipart C, Leborgne J, LeHur PA, Galmiche JP, Denis M, Ruud E, Truchaud A, Lustenberger P. Detection of disseminated tumor cells in peripheral blood of colorectal cancer patients. Int J Cancer 1997, 74(5):540-544. 10.1002/(SICI)1097-0215(19971021)74:5<540::AID-IJC11>3.0.CO;2-A, 9355978.
28. Silva JM, Rodriguez R, Garcia JM, Munoz C, Silva J, Dominguez G, Provencio M, Espana P, Bonilla F. Detection of epithelial tumour RNA in the plasma of colon cancer patients is associated with advanced stages and circulating tumour cells. Gut 2002, 50(4):530-534. 10.1136/gut.50.4.530, 1773179, 11889075.
29. Wang JY, Wu CH, Lu CY, Hsieh JS, Wu DC, Huang SY, Lin SR. Molecular detection of circulating tumor cells in the peripheral blood of patients with colorectal cancer using RT-PCR: significance of the prediction of postoperative metastasis. World J Surg 2006, 30(6):1007-1013. 10.1007/s00268-005-0485-z, 16736329.
30. Li M, Xiao ZQ, Chen ZC, Li JL, Li C, Zhang PF, Li MY. Proteomic analysis of the aging-related proteins in human normal colon epithelial tissue. J Biochem Mol Biol 2007, 40(1):72-81.
31. Kim H, Kim Y, Yoon S, Lim J, Kim M, Lee S, Kang S, Lee EJ, Kang CS, Han K. Rapid fecal cytokeratin-19 test and fecal occult blood test in screening for gastrointestinal diseases. Ann Clin Lab Sci 2006, 36(3):294-298.
32. Pontiggia L, Biedermann T, Meuli M, Widmer D, Böttcher-Haberzeth S, Schiestl C, Schneider J, Braziulis E, Montaño I, Meuli-Simmen C. Markers to evaluate the quality and self-renewing potential of engineered human skin substitutes in vitro and after transplantation. J Invest Dermatol 2009, 129(2):480-490. 10.1038/jid.2008.254, 18719609.
33. Dozois EJ, Boardman LA, Suwanthanma W, Limburg PJ, Cima RR, Bakken JL, Vierkant RA, Aakre JA, Larson DW. Young-onset colorectal cancer in patients with no known genetic predisposition: can we increase early recognition and improve outcome?. Medicine (Baltimore) 2008, 87(5):259-263. 10.1097/MD.0b013e3181881354, 18794708.
34. Lemmon GH, Gardner SN. Predicting the sensitivity and specificity of published real-time PCR assays. Ann Clin Microbiol Antimicrob 2008, 7:18. 10.1186/1476-0711-7-18, 2566554, 18817537.
35. Tsujimoto M, Nakabayashi K, Yoshidome K, Kaneko T, Iwase T, Akiyama F, Kato Y, Tsuda H, Ueda S, Sato K. One-step nucleic acid amplification for intraoperative detection of lymph node metastasis in breast cancer patients. Clin Cancer Res 2007, 13(16):4807-4816. 10.1158/1078-0432.CCR-06-2512, 17699859.
36. Satoh H, Ishikawa H, Fujiwara M, Yamashita YT, Ohtsuka M, Ogata T, Hasegawa S, Kamma H. Production of cytokeratin 19 fragment by human squamous lung cancer cell lines. Am J Respir Cell Mol Biol 1997, 16(5):597-604.
37. Holdenrieder S, Stieber P, Von Pawel J, Raith H, Nagel D, Feldmann K, Seidel D. Early and specific prediction of the therapeutic efficacy in non-small cell lung cancer patients by nucleosomal DNA and cytokeratin-19 fragments. Ann N Y Acad Sci 2006, 1075:244-257. 10.1196/annals.1368.033, 17108218.
38. Nagler R, Bahar G, Shpitzer T, Feinmesser R. Concomitant analysis of salivary tumor markers--a new diagnostic tool for oral cancer. Clin Cancer Res 2006, 12(13):3979-3984. 10.1158/1078-0432.CCR-05-2412, 16818695.
39. Morsi MI, Youssef AI, Hassouna ME, El-Sedafi AS, Ghazal AA, Zaher ER. Telomerase activity, cytokeratin 20 and cytokeratin 19 in urine cells of bladder cancer patients. J Egypt Natl Canc Inst 2006, 18(1):82-93.
40. Le Pimpec-Barthes F, Danel C, Lacave R, Ricci S, Bry X, Lancelin F, Leber C, Milleron B, Fleury-Feith J, Riquet M. Association of CK19 mRNA detection of occult cancer cells in mediastinal lymph nodes in non-small cell lung carcinoma and high risk of early recurrence. Eur J Cancer 2005, 41(2):306-312. 10.1016/j.ejca.2004.09.021, 15661557.